Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is ...

Manas AI Inc., a startup using artificial intelligence to discover new medicines, launched today with $24.6 million in ...

The discovery and development of drugs in pharmacological research – including the risk assessment of active substances in ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

Cofounded by Dr. Siddhartha Mukherjee and Reid Hoffman, Manas AI leverages proprietary AI, generative computational chemistry ...

Discover key considerations for executing workflows in drug discovery, from defining research questions and generating ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

We recently compiled a list of the Top 10 Medical AI Stocks on Wall Street’s Radar. In this article, we are going to take a ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

The global health landscape is constantly challenged by the emergence and re-emergence of viral pathogens. While significant ...

On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial ...